Results 31 to 40 of about 3,014,546 (244)

Lifestyle Modification in Heart Failure Management: Are We Using Evidence-Based Recommendations in Real World Practice? [PDF]

, 2023
The heart failure (HF) guideline's purpose is to assist medical professionals while treating patients with HF in accordance with the best current research. Many cases of HF are both, avoidable and treatable thanks to scientific trials.
강석민
core   +1 more source

Case Report: Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With Worsening Heart Failure—A Successful Resolution Using Non-vitamin K Antagonist Oral Anti-coagulant

Frontiers in Cardiovascular Medicine, 2021
Background: Transcatheter aortic valve replacement (TAVR) is indicated for treating symptomatic severe aortic valve stenosis (AS) with intermediate-to-high surgical risks. Few reports are available on managing leaflet thrombosis after TAVR with worsening
Kae-Woei Liang, Kae-Woei Liang, Chu-Leng Yu, Chu-Leng Yu, Wei-Wen Lin, Wei-Wen Lin, Wei-Wen Lin, Wen-Lieng Lee, Wen-Lieng Lee   +8 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence

ESC Heart Failure
Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in ...
Ruggero Mazzotta, Manuel Garofalo, Samuele Salvi, Matteo Orlandi, Gianluca Marcaccini, Pietro Susini, Luca Checchi, Alberto Palazzuoli, Carlo Di Mario, Maurizio Pieroni, Matteo Beltrami   +10 more
doaj   +1 more source

Serum Myonectin Levels Are Positively Associated With Physical Function and Lower Frailty‐Related Limitation in Maintenance Hemodialysis Patients: A Cross‐Sectional Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and ...
Kenichi Kono, Yoshifumi Moriyama, Koji Ohashi, Naoya Otaka, Minako Tatsumi, Toyoaki Murohara, Noriyuki Ouchi, Satoru Oshima   +7 more
wiley   +1 more source

Abnormal plasma ceramides refine high-risk patients with worsening heart failure

Frontiers in Cardiovascular Medicine, 2023
BackgroundWorsening heart failure (WHF) is a heterogeneous clinical syndrome with poor prognosis. More effective risk stratification tools are required to identify high-risk patients.
Lu Ren, Lu Ren, Fengjuan Li, Fengjuan Li, Xin Tan, Xin Tan, Yangkai Fan, Yangkai Fan, Bingbing Ke, Yixin Zhang, Hongfeng Jiang, Hongfeng Jiang, Lixin Jia, Lixin Jia, Lixin Jia, Yuan Wang, Yuan Wang, Jie Du, Jie Du   +18 more
doaj   +1 more source

Differences in health care use and outcomes by the timing of in-hospital worsening heart failure [PDF]

, 2015
BackgroundPatients hospitalized with acute heart failure may experience worsening symptoms requiring escalation of therapy. In-hospital worsening heart failure is associated with worse in-hospital and postdischarge outcomes, but associations between the ...
Fonarow, Gregg C, DeVore, Adam D., Curtis, Lesley H, Cooper, Lauren B., Hammill, Bradley G., Curtis, Lesley H., Fonarow, Gregg C., Pang, Peter S., Sharma, Puza P, DeVore, Adam D, Cooper, Lauren B, Hernandez, Adrian F, Hernandez, Adrian F., Mentz, Robert J, Mentz, Robert J., Hammill, Bradley G, Pang, Peter S, Sharma, Puza P.   +17 more
core   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure

ESC Heart Failure, 2020
Aims Although tolvaptan has been reported to prevent worsening renal function (WRF) in patients with advanced acute heart failure (AHF), evidence regarding the effect of tolvaptan on renal function in patients with new‐onset AHF is not available.
Hiromi Kin, Koichiro Matsumura, Yoshihiro Yamamoto, Kenichi Fujii, Munemitsu Otagaki, Hiroki Takahashi, Haengnam Park, Kei Yoshioka, Mitsuru Yokoi, Tetsuro Sugiura, Ichiro Shiojima   +10 more
doaj   +1 more source

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure

Cardiac Failure Review, 2020
Hospitalisation for acute heart failure (AHF) is associated with high mortality and high rehospitalisation rates. In the absence of evidence-based therapy, treatment is aimed at stabilisation and symptom relief.
Ingibjörg Kristjánsdóttir, Tonje Thorvaldsen, Lars H Lund   +2 more
doaj   +1 more source